Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation

NCT01800643 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Acute Leukemia
Chronic Leukemia
Lymphoproliferative Disease
Myeloproliferative Disease
Immunodeficiency

Interventions

OTHER: Analyze the pharmacokinetics of busulfan for transplantation

Sponsor

Hospital Israelita Albert Einstein